Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Gastric Cancer

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 11 articles: HTML format

Single Articles

February 2023
1. DHILLON S, Lopes G, Parker JL
   The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer.
   Am J Clin Oncol. 2023;46:58-65.
   PubMed     Abstract available
   
   
   November 2022
2. ZHANG ML, Fan YX, Meng R, Cai WK, et al
   Proton Pump Inhibitors and Cancer Risk: An Umbrella Review and Meta-analysis of Observational Studies.
   Am J Clin Oncol. 2022;45:475-485.
   PubMed     Abstract available
   
   
   September 2022
3. KUMAR R, Tchelebi L, Anker CJ, Sharma N, et al
   American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and Guidelines.
   Am J Clin Oncol. 2022;45:391-402.
   PubMed     Abstract available
   
   
   January 2022
4. PARK JH, Yeo JH, Kim YS, Park I, et al
   Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective Analysis.
   Am J Clin Oncol. 2022 Jan 6. pii: 00000421-900000000-98512.
   PubMed     Abstract available
   
   
   July 2021
5. ABALI H, Yalcin S, Onal HC, Dane F, et al
   A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group
   Am J Clin Oncol. 2021;44:301-307.
   PubMed     Abstract available
   
   
   June 2021
6. MISRA S, Yeshala SK, Singh S, Singh RK, et al
   A Pilot Study of Perioperative Cisplatin-Capecitabine Chemotherapy With Preoperative Chemoradiation for Resectable Gastric Cancers.
   Am J Clin Oncol. 2021 Jun 29. pii: 00000421-900000000-98549.
   PubMed     Abstract available
   
   
   May 2021
7. OGATA T, Narita Y, Kumanishi R, Nakazawa T, et al
   Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer: A Retrospective Cohort Study.
   Am J Clin Oncol. 2021 May 24. pii: 00000421-900000000-98560.
   PubMed     Abstract available
   
   
   April 2021
8. ABDEL-RAHMAN O, Mulder K, Easaw J
   Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer: A Real-world Study.
   Am J Clin Oncol. 2021;44:158-161.
   PubMed     Abstract available
   
   
   March 2021
9. PARK JH, Yeo JH, Kim YS, Park I, et al
   Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy.
   Am J Clin Oncol. 2021 Mar 12. pii: 00000421-900000000-98590.
   PubMed     Abstract available
   
   
   November 2020
10. DE LEO AN, Bates JE, Lockney NA, Mendenhall NP, et al
    Radiotherapy in Early-stage Gastric MALT: Improved Survival Without Increased Cardiac Death.
    Am J Clin Oncol. 2020;43:770-775.
    PubMed     Abstract available
    
    
    October 2020
11. DIAZ DEL ARCO C, Estrada Munoz L, Sanchez Pernaute A, Ortega Medina L, et al
    Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
    Am J Clin Oncol. 2020 Oct 20. doi: 10.1097/COC.0000000000000770.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: